Human monoclonal antibodies against AXL
US10398774B2 · kind B2 · utility
0Cited by
10References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 8, 2015 |
| Grant date | Sep 3, 2019 |
| Priority date | — |
| Expiry date | Feb 12, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides human monoclonal antibodies and antibody-drug conjugates against AXL and their use for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.